Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon E Hopcraft

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 13, 2017
Tumour viruses and innate immunitySharon E Hopcraft, Blossom Damania
Hepatology (Baltimore, Md.)|March 31, 2015
Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudinsSharon E Hopcraft, Matthew J Evans
Hepatology (Baltimore, Md.)|November 5, 2015
Liver capsule: Hepatitis C virus host cell entrySharon E Hopcraft, Matthew J Evans
Msphere|July 20, 2018
Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal CarcinomaSharon E Hopcraft, Cary A Moody, Blossom Damania
Plos Pathogens|September 14, 2018
Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latencySharon E Hopcraft, Samantha G Pattenden, Lindsey I James, et al.
Journal of Virology|September 17, 2010
Species-specific regions of occludin required by hepatitis C virus for cell entryMaria L Michta, Sharon E Hopcraft, Christopher M Narbus, et al.
Mbio|August 15, 2025
KSHV and HPV modulate epithelial-to-mesenchymal transition in oral epithelial cellsQian Li, Sharon E Hopcraft, Philip T Lange, et al.
Plos Pathogens|May 2, 2017
NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latencyZhe Ma, Sharon E Hopcraft, Fan Yang, et al.
Journal of Virology|September 16, 2011
HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycleChristopher M Narbus, Benjamin Israelow, Marion Sourisseau, et al.
Plos Pathogens|April 5, 2013
Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodiesMarion Sourisseau, Maria L Michta, Chati Zony, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 13, 2017
Tumour viruses and innate immunitySharon E Hopcraft, Blossom Damania
Hepatology (Baltimore, Md.)|March 31, 2015
Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudinsSharon E Hopcraft, Matthew J Evans
Hepatology (Baltimore, Md.)|November 5, 2015
Liver capsule: Hepatitis C virus host cell entrySharon E Hopcraft, Matthew J Evans
Msphere|July 20, 2018
Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal CarcinomaSharon E Hopcraft, Cary A Moody, Blossom Damania
Plos Pathogens|September 14, 2018
Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latencySharon E Hopcraft, Samantha G Pattenden, Lindsey I James, et al.
Journal of Virology|September 17, 2010
Species-specific regions of occludin required by hepatitis C virus for cell entryMaria L Michta, Sharon E Hopcraft, Christopher M Narbus, et al.
Mbio|August 15, 2025
KSHV and HPV modulate epithelial-to-mesenchymal transition in oral epithelial cellsQian Li, Sharon E Hopcraft, Philip T Lange, et al.
Plos Pathogens|May 2, 2017
NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latencyZhe Ma, Sharon E Hopcraft, Fan Yang, et al.
Journal of Virology|September 16, 2011
HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycleChristopher M Narbus, Benjamin Israelow, Marion Sourisseau, et al.
Plos Pathogens|April 5, 2013
Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodiesMarion Sourisseau, Maria L Michta, Chati Zony, et al.
Pageof 2